Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LABCORP HOLDINGS INC. Director's Dealing 2021

Jun 9, 2021

30237_dirs_2021-06-09_3f3e6214-2596-4002-a12e-0facaaa6e40a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2021-06-07

Reporting Person: van der Vaart Sandra D (EVP, Chief Legal Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-06-07 Common Stock M 4500 $84.86 Acquired 9737.0415 Direct
2021-06-07 Common Stock S 4500 $266.56 Disposed 5237.0415 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-06-07 Non-qualified Stock Options $84.86 M 4500 Disposed 2022-05-23 Common Stock (4500) Direct

Footnotes

F1: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.

F2: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2012 Omnibus Incentive Plan.

F3: The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable.